Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-020555
Filing Date
2025-03-05
Accepted
2025-03-05 06:05:54
Documents
7
Effectiveness Date
2025-03-05

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm258209d1_s8.htm S-8 44205
2 EXHIBIT 5.1 tm258209d1_ex5-1.htm EX-5.1 10511
3 EXHIBIT 23.2 tm258209d1_ex23-2.htm EX-23.2 2446
4 EX-FILING FEES tm258209d1_ex-filingfees.htm EX-FILING FEES 9694
5 GRAPHIC tm258209d1_ex5-1img001.jpg GRAPHIC 3634
6 GRAPHIC tm258209d1_ex5-1img002.jpg GRAPHIC 8705
7 GRAPHIC tm258209d1_ex5-1img003.jpg GRAPHIC 7196
  Complete submission text file 0001104659-25-020555.txt   95380
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285549 | Film No.: 25708611
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)